Severe or even fatal pulmonary toxicity.
Avoid combination due to severe pulmonary toxicity.
Source: G&G 14e
Antimetabolite · Antineoplastic
Also known as Nipent, 2′-deoxycoformycin
Pentostatin (2'-deoxycoformycin) is a potent irreversible inhibitor of adenosine deaminase (ADA), the enzyme that catalyzes the deamination of adenosine and deoxyadenosine. ADA inhibition causes intracellular accumulation of deoxyadenosine triphosphate (dATP), which inhibits ribonucleotide reductase and S-adenosylhomocysteine hydrolase, leading to impaired DNA synthesis and apoptosis. Lymphocytes are particularly sensitive because of their high ADA activity and dependence on the purine salvage pathway, making pentostatin highly effective in hairy cell leukemia.
Avoid (teratogenic in animal studies).
Discontinue breast-feeding.
Severe or even fatal pulmonary toxicity.
Avoid combination due to severe pulmonary toxicity.
Source: G&G 14e
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Clinical effect not specified
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Katzung·Verified: 2026-05-10 · House clinical team